Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Terry Chamberlin"'
Autor:
Lily Y. Liu, John Nemunaitis, Jodi Cutler, Paul Schwarzenberger, Casey Cunningham, Neil Senzer, Habib Fakhrai, Edward DeVol, Beena O. Pappen, Robert O. Dillman, Phillip B. Maples, Daniel L. Shawler, Padmasini Kumar, Terry Chamberlin, Alex W. Tong, Cody Hamilton
Publikováno v:
Journal of Clinical Oncology. 24:4721-4730
PurposeBelagenpumatucel-L is a nonviral gene-based allogeneic tumor cell vaccine that demonstrates enhancement of tumor antigen recognition as a result of transforming growth factor beta-2 inhibition.Patients and MethodsWe performed a randomized, dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23cce29b5d5ca662d700d1691aed201
https://doi.org/10.1200/jco.2005.05.5335
https://doi.org/10.1200/jco.2005.05.5335
Autor:
Sara-Jane Onyeama, Loren K. Mell, Yong A. Yu, Robert A. Weisman, Alexa Frentzen, Parag Sanghvi, Qian Zhang, Anu Pold, M.E. Wright, Gregory A. Daniels, Aladar A. Szalay, Kevin T. Brumund, Sunil J. Advani, Peter Martin, Terry Chamberlin
Publikováno v:
Journal of Clinical Oncology. 33:6026-6026
6026 Background: We aimed to test the safety of GL-ONC1, an attenuated vaccinia virus, delivered intravenously (IV) with concurrent CRT for locoregionally advanced head and neck carcinoma (LA-HNC)....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d471098fcf61fa3832364229d83bbf3b
https://doi.org/10.1200/jco.2015.33.15_suppl.6026
https://doi.org/10.1200/jco.2015.33.15_suppl.6026
Publikováno v:
Global Solutions for Urban Drainage.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8e481602b12283c6b6cd6fe7d22e7ea
https://doi.org/10.1061/40644(2002)186
https://doi.org/10.1061/40644(2002)186
Autor:
Edward DeVol, Habib Fakhrai, Padmasini Kumar, Beena O. Pappen, Alex W. Tong, Jodi Cutler, Lily Liu, Terry Chamberlin, John Nemunaitis, Paul Schwarzenberger, Daniel L. Shawler, Robert O. Dillman, Cody Hamilton, Neil Senzer, Casey Cunningham, Phillip B. Maples
Publikováno v:
Molecular Therapy. 13:S424-S425
Top of pageAbstract Lucanix|[trade]| is a non-viral gene based allogeneic tumor cell vaccine. Preclinical studies demonstrate enhancement of tumor antigen recognition as a result of TGF-|[beta]|2 inhibition. We performed a randomized dose variable ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c5ae93ae1f09101cab812c3f6494e7
https://doi.org/10.1016/j.ymthe.2006.08.1209
https://doi.org/10.1016/j.ymthe.2006.08.1209